-
61
Six months of hybrid closed-loop therapy improves diabetes-specific positive well-being, and reduces diabetes distress and fear of hypoglycemia: secondary analysis of a randomized controlled trial
Published 2024-12-01“…Psychological outcomes (awareness and fear of hypoglycemia; and diabetes-specific positive well-being, diabetes distress, diabetes treatment satisfaction, and diabetes-specific quality of life (QoL)) were measured at enrollment, mid-trial and end-trial. …”
Get full text
Article -
62
Evaluation of machine learning-based regression techniques for prediction of diabetes levels fluctuations
Published 2025-01-01Subjects: Get full text
Article -
63
An application of natural language processing for hypoglycemic event identification in patients with diabetes mellitus
Published 2025-06-01Subjects: Get full text
Article -
64
Insulin autoimmune syndrome in a 3-year-old boy: the youngest to date in China and a narrow review
Published 2025-02-01Subjects: Get full text
Article -
65
Sildenafil alters biogenic amines and increases oxidative damage in brain regions of insulin-hypoglycemic rats
Published 2020-03-01Subjects: Get full text
Article -
66
The role of clinical pharmacists in improving diabetic care of hospitalized heart patients
Published 2025-01-01Subjects: Get full text
Article -
67
The effect of renal function on the clinical outcomes and management of patients hospitalized with hyperglycemic crises
Published 2025-01-01Subjects: Get full text
Article -
68
-
69
-
70
-
71
-
72
-
73
Research status of ambulatory blood glucose monitoring in patients with type 2 diabetes mellitus (动态血糖监测在2型糖尿病患者中应用研究现状)
Published 2022-12-01Subjects: Get full text
Article -
74
Confirmation of the Absence of Somogyi Effect in Patients with Type 2 Diabetes by Retrospective Continuous Glucose Monitoring Systems
Published 2022-01-01“…The Somogyi effect is defined as fasting hyperglycemia secondary to nocturnal hypoglycemia. In past decades, this effect proved to be rare or absent. …”
Get full text
Article -
75
Meta-Analysis of 11 Heterogeneous Studies regarding Dipeptidyl Peptidase 4 Inhibitor Add-On Therapy for Type 2 Diabetes Mellitus Patients Treated with Insulin
Published 2020-01-01“…Regarding the incidence of hypoglycemia, we suspected that the heterogeneity was caused by differences in the definition of hypoglycemia among the studies. …”
Get full text
Article -
76
Biochemical and Clinical Features of Insulinoma in a Patient with Turner Syndrome
Published 2019-01-01“…Impaired counterregulatory response to hypoglycemia in patients with TS may result in symptomatic hypoglycemia with only mild insulin elevation and elevated proinsulin in setting of hypoglycemia may be the only indication of insulinoma in these patients. …”
Get full text
Article -
77
Vida Saludable: Hiperglicemia e Hipoglicemia
Published 2007-01-01“…FCS8820-Span, a 3-page fact sheet by Jennifer Hillan, is the Spanish version of "Healthy Living: Hyperglycemia and Hypoglycemia" (FCS8820/FY885). It will help patients with diabetes understand how to detect, treat, and prevent hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar). …”
Get full text
Article -
78
Insulin Autoimmune Syndrome: A Systematic Review
Published 2023-01-01“…Insulin autoimmune syndrome (IAS) is a rare endocrine disorder characterized by recurrent episodes of severe hypoglycemia, markedly elevated serum insulin, and positive insulin autoantibodies. …”
Get full text
Article -
79
Vida Saludable: Hiperglicemia e Hipoglicemia
Published 2007-01-01“…FCS8820-Span, a 3-page fact sheet by Jennifer Hillan, is the Spanish version of "Healthy Living: Hyperglycemia and Hypoglycemia" (FCS8820/FY885). It will help patients with diabetes understand how to detect, treat, and prevent hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar). …”
Get full text
Article -
80
A safe-enhanced fully closed-loop artificial pancreas controller based on deep reinforcement learning.
Published 2025-01-01“…Additionally, a dual safety mechanism of 'proactive guidance + reactive correction' was introduced to reduce the risks of hyperglycemia and hypoglycemia and to prevent emergencies. Performance evaluations in the Simglucose simulator demonstrate that the proposed controller achieved an 87.45% time in range (TIR) median, superior to baseline methods, with a lower incidence of hypoglycemia, notably eliminating severe hypoglycemia and treatment failures. …”
Get full text
Article